3D BioFibR secures seed financing to commercialise proprietary platform
Biomaterial manufacturing company 3D BioFibR has raised US$550,000 to fund development and commercialisation of its tissue engineering/biomedical device products and to scale up manufacturing of its novel biofibre-based platform.
This investment comes from a consortium of private investors, including US$150,000 from Concrete Ventures and US$100,000 from Innovacorp.
For the full story, see the November 2020 edition of Medical Textiles.